Overexpression of CDC20 predicts poor prognosis in primary non-small cell lung cancer patients
Journal of Surgical Oncology, 05/04/2012
Kato T et al. – CDC20 was a negative prognostic marker with significance in patients with resected non–small cell lung cancer (NSCLC), particularly those with ADC histology. These results provide additional information for determining postoperative adjuvant treatment.